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Introduction: It is well recognized that liver involvement in Cystic Fibrosis (CF)
patients is associated with a more adverse outcome. Although no perfect method of
assessing hepatobiliary involvement in CF is currently available, abdominal ultra-
sound (AUS) and biochemical evaluation have been used to identify liver disease
at an early stage. Considering the scarce information in Portuguese CF patients, we
aimed to evaluate liver involvement in CF pediatric patients.
Methods: Observational/cross-sectional study in CF children, concerning the most
recent liver evaluation (clinical, AUS and 1 biochemical evaluation).
Results: A total of 24 patients were included (median 10 years [1−18]; 9 males). All
patients had pancreatic insufﬁciency; 23 had F508del mutation (17 homozygous).
Ten patients (42%) had a normal evaluation (clinical, AUS, analytic) and the other
patients (except 1) had AUS abnormalities.
Eight patients had hepatomegaly and from these 4 had splenomegaly.
AUS features included: heterogeneous echogenicity of hepatic parenchyma (11/24),
with nodularity additionally present in 5/24, homogenous echogenicity (2/24),
hepatomegaly (8/24) and esplenomegaly (4/24). Only 6 patients had AST/ALT
or/and G-GT alterations.
Ursodeoxycholic acid therapy was instituted in patients with major liver involve-
ment. In 3 patients submitted to upper endoscopy the presence of esophageal varices
was conﬁrmed and 2 are currently under variceal ligation program.
Conclusion: Despite the retrospective nature of the present data, a relatively high
frequency of liver involvement in CF patients has been shown. We emphasize the
diagnostic contribution of US evaluation as previously reported.
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Background: Liver cirrhosis is the end stage of cystic ﬁbrosis liver disease (CFLD)
with an important implication on disease’s outcome. Vascular complication, with
occurrence of portal hypertension is an alarming stage considering the risk of
variceal bleeding.
Objectives: Evaluation of severe liver disease with portal hypertension (PH) in
CF patients and identiﬁcation of its prevalence and risk factors.
Methods: Study evaluated prospectively, 159 patients for ﬁve years. They were
routinely followed-up by clinical assessment, liver biochemical tests, ultrasound
examinations (US); transient elastography, MRI, endoscopy.
Results: Fifty ﬁve patients, median age at diagnosis = 12.4 years were diagnosed
with CFLD, with slight predominance of boys. Severe liver disease occurred in
11 patients (20%) of which 5 with oesophageal varices. All of them had history
of meconium ileus and homozygous for F508del; 4 were boys. CFLC occurred
more frequently in patients aged over 10 yrs. Pancreatic insufﬁciency and severe
mutations was strongly associated with PH.
Conclusion: CF children older than 10 year, with history of meconium ileus,
pancreatic insufﬁciency and severe mutation were more likely predisposed to liver
cirrhosis with portal hypertension. Further studies should follow risk factor for
development of CFLD and how they can be inﬂuenced, in order to prevent the
development of liver cirrhosis.
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Patients with cystic ﬁbrosis (CF) are deemed at risk of developing urinary inconti-
nence (UI) due to repeated coughing and other factors causing increased pressure
on the pelvic ﬂoor. Fecal incontinence (FI) is derived from the same mechanism
but only very few data are available on its frequency. The aim was to establish the
prevalence of FI in an adult population with CF.
Patients were recruited from Marseille referral center for adult CF. They were asked
to ﬁll in a self-completed anonymous questionnaire for symptom assessment of UI
(Urinary Symptom Proﬁle score) and FI (St Mark Hospital score). Clinical data
and medical history were also recorded.
122 out of 190 patients completed the survey (79M/43F, mean age 30.9 yr [range
18−65], 59 [48%] were lung transplanted). Mean FEV1 was 67.3±28% predicted.
Symptoms of FI were reported by 37 patients (30%, 24F [56%], 13M [16%])
and of UI by 31 patients (25.4%, 28F [65%], 3M [4%]). For 17 patients (14%,
14F [32.5%]) UI and FI were present. FI was signiﬁcantly more frequent in
older patients (34.27 yr vs 29.54 yr, p = 0.03) and in patient with associated UI
(p = 0.001). No relationship was found between respiratory, bacterial, nutritional
status, transplantation, pancreatic status, practice of physiotherapy, delivery history
and FI.
In this preliminary study, FI prevalence is high in the CF adult population especially
in women. It may also lead to potential deterioration of respiratory status due
to reduced adherence to forced expiratory maneuvers aiming at avoiding the
occurrence of FI and UI. This population needs to be aware of the problem of
FI and UI as it is a treatable condition and could potentially be prevented.
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Introduction: Average age in the adult CF population is permanently increasing
predisposing to a higher rate of malignancies. The previous survey on cases of
malignancies in CF adults at Stockholm CF center revealed a growing number of
malignancies with gastrointestinal (GI) cancer being predominant.
The aim of the study was to survey cases of malignancies in non-transplanted CF
adults (n = ca 600) at the Scandinavian (Sweden, Denmark and Norway) CF centers.
The retrospective case analysis performed in CF adults revealed 18 cases of
malignancies during the last decades. Nine patients had different forms of GI
cancer (adenocarcinoma of colon, cholangiocarcinoma, adenocarcinoma of small
intestine, gingival cancer as well as cancer of pancreas). Three patients had tumours
of hematological origin (myeloma, acute lymphoblastic leukemia, and lymphoma).
Four patients had tumours in endocrine organs (seminoma, thyriod cancer and cancer
of ovarii). Two patients had cervical cancer and melanoma, respectively.
Further analysis disclosed ﬁve cases of benign tumours. In four of these pathology
was found within GI tract (colon polyposis (3) and duodenal adenoma (1)). In two
of the patients with colon polyposis GI cancer was later diagnosed (included above).
Patient age varied between 25 and 65 years. Mean age for GI cancer was 48 years
(39−65).
In children there were two cases of malignancies: Langerhans cell histiocytosis and
acute lymphoblastic leukemia.
Conclusion: The data from Scandinavian CF centers demonstrates that GI cancer
is the dominating form of malignancies among CF adults. However, one has to be
aware of tumours of hematological and endocrine origin in CF patients.
